---
name: SciQuus Oncology
slug: sciquus
site: cro
website_domain: sciquus.com
summary: Full-service oncology CRO specializing in First-in-Human studies and clinical trial management from preclinical IND enabling through Phase III, with decades of expertise across oncologic and hematologic indications.
tagline: Oncology CRO specializing in First-in-Human and complex cancer trials with decades of clinical expertise.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-13T07:02:01.831Z
services_count: 8
modalities_count: 0
indications_count: 1
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# SciQuus Oncology

Oncology CRO specializing in First-in-Human and complex cancer trials with decades of clinical expertise.

Listed on cro.directory.

## Summary

Full-service oncology CRO specializing in First-in-Human studies and clinical trial management from preclinical IND enabling through Phase III, with decades of expertise across oncologic and hematologic indications.

## Services

- Oncology Specialty Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- US FDA Regulatory Strategy
- Regulatory Affairs
- In Vivo PK / PD Studies

## Indications

- Oncology

## Long description

## Overview

SciQuus Oncology is a full-service contract research organization dedicated to oncology and hematology clinical trials. The company specializes in First-in-Human studies for new cancer therapies and offers a comprehensive range of services spanning preclinical development through Phase III clinical trials.

## Core Capabilities

**Preclinical Development:** Expert-driven IND enabling studies and FDA consultations to guide innovation from discovery through regulatory submission.

**Clinical Development:** End-to-end trial management including protocol design, site selection, patient recruitment, and Phase I–III trial execution with rigorous quality standards.

**Pharmacology & PK/PD:** Specialized advice on pharmacology and pharmacokinetic/pharmacodynamic analyses to optimize drug development outcomes.

**Oncology & Hematology Expertise:** Proven solutions for complex oncologic and hematologic clinical research trials, with experience managing over 40 trials involving more than 850 patients across a broad spectrum of indications.

## Differentiation

The company emphasizes senior leadership continuity, flexibility to adapt to changing trial priorities, and seamless integration with sponsor teams. SciQuus operates with a customized approach to each project, offering flexibility in engagement models—full program management or targeted functional support.

## Related companies

- [Proxima Clinical Research](/companies/proximacro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/proximacro/sciquus)
- [Sacura GmbH](/companies/sacura-cro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/sacura-cro/sciquus)
- [SMO India Clinical Research Pvt Ltd](/companies/smo-india) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/sciquus/smo-india)
- [ERGOMED Group](/companies/ergomed) (Oncology Specialty Services, Phase I Clinical Trials) — [Compare](/compare/ergomed/sciquus)
- [CMIC HOLDINGS Co., Ltd.](/companies/cmicgroup) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/cmicgroup/sciquus)
- [Volumetryx](/companies/volumetryx) (Oncology Specialty Services, Phase I Clinical Trials) — [Compare](/compare/sciquus/volumetryx)
- [Ergomed Clinical Research](/companies/medsource) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/medsource/sciquus)
- [Emerald Clinical](/companies/emeraldclinical) (Oncology Specialty Services, Phase I Clinical Trials) — [Compare](/compare/emeraldclinical/sciquus)

_Profile last updated: 2026-10-13T07:02:01.831Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.